Endpoint · extractionPOSTapi.magentlab.com /api/calc/prevail
Armstrong 2018 PREVAIL Cox linear predictor for overall survival in chemotherapy-naïve metastatic castration-resistant prostate cancer from albumin, ALP versus ULN, bone…
Read more
Armstrong 2018 PREVAIL Cox linear predictor for overall survival in chemotherapy-naïve metastatic castration-resistant prostate cancer from albumin, ALP versus ULN, bone metastases under 10, hemoglobin, LDH versus ULN, NLR under 2.5, pain 0-1, liver metastases, ln(PSA), months from diagnosis, and enzalutamide versus placebo. Table 1 HRs as ln(HR). Not a 1-/2-/3-year OS percent (no published S0). magent does not read bone scans. Not a dose or treatment order.Overview
Grade?
UNRATED
0 of 30 paid calls toward a letter
Price
$0.005 per call
Paid calls
none yet
delivery unknown until someone pays
More info
Seller?
URL
https://api.magentlab.com/api/calc/prevail
Seen
first 29 days ago · last 15 hr ago
25 free handshakes
Payment
Pays through
x402
Offered on?
Base USDC
Listed on?
Base
Handshakescomputed 1 day ago
0.260 from 24 free handshakes over 30 days · UNRATED ?
| Component | Weight | Measured | Lower bound ? | Adds | Short ? | Uncertain ? | |
|---|---|---|---|---|---|---|---|
| livenesscosts the most it answered at all |
0.60 | 0.61 | 0.099 | 0.060 | −0.233 | −0.307 | |
| latency p95 it answered as fast as its class |
0.20 | 0.00 | 0.000 | 0.000 | −0.200 | 0 | |
| price stability the price stayed where it was listed |
0.20 | 1.00 | 1.000 | 0.200 | 0 | 0 | |
| Composite | 1.00 | 0.260 | gap to 1.000 = 0.740 · 0.433 short · 0.307 uncertain | 0.260 | −0.433 | −0.307 |
Not measured: correctness · nobody paid; honesty · nobody paid; schema conformance · no answer had a published shape to check
BURN_INFREE_TIER_ONLY
Verify it yourself
npx teppi-check https://api.magentlab.com/api/calc/prevailcurl -s https://api.teppi.xyz/v1/trust/cap_01M1RD9JK1QB7NS77N354NW5G1